6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
10m ago	Ideal Power to Host First Quarter 2026 Results Conference Call on May 14, 2026 at 10:00 AM Eastern Time
11m ago	OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026
11m ago	Euroseas Ltd. Announces Expansion of its Feeder Containership Newbuilding Program Ordering Two 2,800 teu High-Reefer Vessels and Two 1,800 teu Vessels
12m ago	Boxlight Announces Significant Upgrades to Symphony™ Campuswide Communication Platform
12m ago	Satellogic Signs $12 Million Agreement to Deliver In-Orbit NewSat Satellite to Sovereign Defense Customer

About

Eledon Pharmaceuticals Inc (NASDAQ:ELDN) — investor relations, events, news, and company updates on 6ix.

Latest News

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine

Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation

NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes

Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference

Financials

Revenue

$0

Market Cap

$244.47 M

EPS

-0.52

Community Chat

Ask AI